IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $254,000 | -0.4% | 237,000 | 0.0% | 0.00% | – |
| Q4 2020 | $255,000 | +810.7% | 237,000 | +777.8% | 0.00% | – |
| Q2 2020 | $28,000 | -97.6% | 27,000 | -97.7% | 0.00% | – |
| Q3 2019 | $1,164,000 | -70.6% | 1,168,000 | -68.6% | 0.00% | -100.0% |
| Q2 2019 | $3,964,000 | +995.0% | 3,718,000 | +1232.6% | 0.00% | – |
| Q3 2018 | $362,000 | +196.7% | 279,000 | +203.3% | 0.00% | – |
| Q2 2018 | $122,000 | -97.4% | 92,000 | -97.7% | 0.00% | -100.0% |
| Q4 2017 | $4,728,000 | +77.5% | 4,085,000 | +82.3% | 0.00% | – |
| Q3 2017 | $2,663,000 | +3.7% | 2,241,000 | +16.8% | 0.00% | -100.0% |
| Q2 2017 | $2,567,000 | +428.2% | 1,918,000 | +390.5% | 0.00% | – |
| Q1 2017 | $486,000 | +124.0% | 391,000 | +105.8% | 0.00% | – |
| Q4 2016 | $217,000 | – | 190,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 9,000 | $9,953,000 | 0.83% |
| CSS LLC/IL | 10,119,000 | $11,031,000 | 0.46% |
| DeepCurrents Investment Group LLC | 13,556,000 | $14,917,000 | 0.45% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $11,014,000 | 0.24% |
| WOLVERINE ASSET MANAGEMENT LLC | 28,592,000 | $31,218,000 | 0.24% |
| HBK INVESTMENTS L P | 14,616,000 | $15,971,000 | 0.06% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,127,000 | $2,334,000 | 0.05% |
| Verition Fund Management LLC | 3,942,000 | $4,304,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 10,037,000 | $10,959,000 | 0.01% |
| Calamos Advisors LLC | 2,423,000 | $2,648,000 | 0.01% |